CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...